APG101 in Myelodysplastic Syndrome
Clinical trial NCT01736436 · COMPLETED
Trial details
- NCT number
- NCT01736436
- Sponsor
- Apogenix GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.